Polypharmacy in attention deficit hyperactivity disorder treatment: current status, challenges and next steps.
Department of Psychiatry, College of Medicine, Clinical and Health Psychology, College of Public Health and Health Professions, Room HD-G-20, Human Development Building, Box 100234, University of Florida, Gainesville, FL 32610, USA. rbussing@ufl.edu
Regina
R
Bussing
Almut G
AG
Winterstein
D000928:Antidepressive Agents / Q000008:administration & dosage*; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D015259:Dopamine Agents / Q000008:administration & dosage*; D006801:Humans; D019338:Polypharmacy
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D015259:Dopamine Agents